nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Announcement
|
|
|
1996 |
|
1 |
p. 75- 1 p. |
artikel |
2 |
An optimized method for cell-based phage display panning
|
Watters, Jennifer M. |
|
1997 |
|
1 |
p. 21-29 9 p. |
artikel |
3 |
Antibody phage display technology and its applications
|
Hoogenboom, Hennie R |
|
1998 |
|
1 |
p. 1-20 20 p. |
artikel |
4 |
Anti-colorectal cancer antibodies by phage display
|
Hoogenboom, H.R. |
|
1996 |
|
1 |
p. 67- 1 p. |
artikel |
5 |
Antigen-specific activation of B cells in vitro after recruitment of T cell help with superantigen
|
Ingvarsson, Sigurdur |
|
1995 |
|
1 |
p. 29-39 11 p. |
artikel |
6 |
Anti-microbial activity of human CAP18 peptides
|
Larrick, James W. |
|
1995 |
|
1 |
p. 65-72 8 p. |
artikel |
7 |
Characterization of anti-mouse FcγRII single-chain Fv fragments derived from human phage display libraries
|
McCall, A.M |
|
1998 |
|
1 |
p. 71-87 17 p. |
artikel |
8 |
Cloning and expression of human V-genes derived from phage display libraries as fully assembled human anti-TNFα monoclonal antibodies
|
Mahler, Stephen M. |
|
1997 |
|
1 |
p. 31-43 13 p. |
artikel |
9 |
Design, expression and 3-D structure of bifunctional single chain Ig-like molecules
|
Hudson, P. |
|
1996 |
|
1 |
p. 68- 1 p. |
artikel |
10 |
Determinants of selective tumor targeting by single-chain Fv molecules
|
Weiner, L.M. |
|
1996 |
|
1 |
p. 73- 1 p. |
artikel |
11 |
Editorial
|
Borrebaeck, Carl A.K. |
|
1996 |
|
1 |
p. 1- 1 p. |
artikel |
12 |
Editorial
|
Borrebaeck, Carl A.K. |
|
1997 |
|
1 |
p. 1- 1 p. |
artikel |
13 |
Editorial
|
Borrebaeck, Carl A.K. |
|
1995 |
|
1 |
p. ix- 1 p. |
artikel |
14 |
Editorial Board
|
|
|
1996 |
|
1 |
p. IFC- 1 p. |
artikel |
15 |
Editorial Board
|
|
|
1997 |
|
1 |
p. IFC- 1 p. |
artikel |
16 |
Editorial Board
|
|
|
1995 |
|
1 |
p. ii-iii nvt p. |
artikel |
17 |
Engineering ultra high affinity human anti-c-erbB-2 single-chain Fv using phage display
|
Schier, R. |
|
1996 |
|
1 |
p. 71-72 2 p. |
artikel |
18 |
Epitope mapping, V-region DNA sequence, and neutralizing Fab fragments of two monoclonal antibodies against the HIV-1 V3 loop
|
Duarte, Carlos A. |
|
1996 |
|
1 |
p. 11-20 10 p. |
artikel |
19 |
Expression in Escherichia coli of soluble and M13 phage-displayed forms of a single-chain antibody fragment specific for digoxin: assessment in a novel drug immunoassay
|
Navarro-Teulon, Isabelle |
|
1995 |
|
1 |
p. 41-52 12 p. |
artikel |
20 |
Fine tuning of an anti-testosterone antibody binding site by stepwise optimisation of the CDRs
|
Hemminki, Ari |
|
1998 |
|
1 |
p. 59-69 11 p. |
artikel |
21 |
Genetically engineered antibodies with improved functional properties
|
Morrison, S.L. |
|
1996 |
|
1 |
p. 69-70 2 p. |
artikel |
22 |
Harlequin granulocyte-colony stimulating factor interleukin 6 molecules with bifunctional and antagonistic activities
|
Grazia Cusi, M. |
|
1997 |
|
1 |
p. 61-69 9 p. |
artikel |
23 |
Homogeneous antigen-specific selection of phage displayed antibodies
|
Borrebaeck, C.A.K. |
|
1996 |
|
1 |
p. 65- 1 p. |
artikel |
24 |
Human antibody libraries
|
Vaughan, T.J. |
|
1996 |
|
1 |
p. 72-73 2 p. |
artikel |
25 |
Humanization of a mouse monoclonal antibody that blocks the epidermal growth factor receptor: recovery of antagonistic activity
|
Mateo, Cristina |
|
1997 |
|
1 |
p. 71-81 11 p. |
artikel |
26 |
Humanization of an antibody recognizing a breast cancer specific epitope by CDR-grafting
|
Fiorentini, Simona |
|
1997 |
|
1 |
p. 45-59 15 p. |
artikel |
27 |
Humanized anti-CD11a: research and clinical perspectives
|
Presta, L. |
|
1996 |
|
1 |
p. 70-71 2 p. |
artikel |
28 |
Human monoclonal Fab fragments specific for viral antigens from combinatorial IgA libraries
|
de Alborán, Ignacio Moreno |
|
1995 |
|
1 |
p. 21-28 8 p. |
artikel |
29 |
Identification of epitope recognized by an anti-c-myc monoclonal antibody that cross-reacts with E. coli sigma factor using phage display libraries
|
Ikegaki, Naohiko |
|
1996 |
|
1 |
p. 37-46 10 p. |
artikel |
30 |
Immunoglobulin G abnormalities in HIV-1 infected individuals with lymphoma
|
Lundholm, Peter |
|
1998 |
|
1 |
p. 29-36 8 p. |
artikel |
31 |
Immunotherapy of relapsed B-cell lymphoma with an anti-CD20 antibody (IDEC-C2B8)
|
Grillo-López, A.J. |
|
1996 |
|
1 |
p. 65-66 2 p. |
artikel |
32 |
Intracellular antibodies (intrabodies) as research reagents and therapeutic molecules for gene therapy
|
Marasco, Wayne A. |
|
1995 |
|
1 |
p. 1-19 19 p. |
artikel |
33 |
In vitro and in vivo characterisation of a recombinant carboxypeptidase G2::anti-CEA scFv fusion protein
|
Michael, N.Paul |
|
1996 |
|
1 |
p. 47-57 11 p. |
artikel |
34 |
In vitro and in vivo characterization of a human anti-c-erbB-2 single-chain Fv isolated from a filamentous phage antibody library
|
Schier, Robert |
|
1995 |
|
1 |
p. 73-81 9 p. |
artikel |
35 |
Kinetic and affinity constants of epitope specific anti-carcinoembryonic antigen (CEA) monoclonal antibodies for CEA and engineered CEA domain constructs
|
Hefta, Laura J.F |
|
1998 |
|
1 |
p. 49-57 9 p. |
artikel |
36 |
‘Knobs-into-holes’ provides a rational design strategy for engineering antibody CH3 domains for heavy chain heterodimerization
|
Carter, P. |
|
1996 |
|
1 |
p. 73- 1 p. |
artikel |
37 |
Meeting report from the ‘Therapeutic Antibody Technology 95’ meeting — Not just ‘another recombinant antibody meeting’
|
Larrick, James W. |
|
1996 |
|
1 |
p. 59-63 5 p. |
artikel |
38 |
Monoclonal antibodies for the treatment of solid tumors
|
Hetlström, I. |
|
1996 |
|
1 |
p. 66-67 2 p. |
artikel |
39 |
Monoclonal antibody against pIII of filamentous phage: an immunological tool to study pIII fusion protein expression in phage display systems
|
Tesar, Michael |
|
1995 |
|
1 |
p. 53-64 12 p. |
artikel |
40 |
Perfecting single chain Fv imaging agents
|
Huston, J.S. |
|
1996 |
|
1 |
p. 67-68 2 p. |
artikel |
41 |
Phage-display library selection and mutation for the engineering of antibody affinity
|
Irving, R. |
|
1996 |
|
1 |
p. 69- 1 p. |
artikel |
42 |
Production of secretory IgA antibodies in plants
|
Hein, M.B. |
|
1996 |
|
1 |
p. 66- 1 p. |
artikel |
43 |
Rapid diagnosis of HIV1 and HIV2 using recombinant Fab and extended scFvs
|
Lilley, G.G. |
|
1996 |
|
1 |
p. 68-69 2 p. |
artikel |
44 |
RSHZ19, a reshaped human Mab for the treatment and prevention of severe RSV infection
|
Porter, T. |
|
1996 |
|
1 |
p. 71- 1 p. |
artikel |
45 |
Selection of phage displayed peptides from a random 10-mer library recognising a peptide target
|
Bremnes, Toril |
|
1998 |
|
1 |
p. 21-28 8 p. |
artikel |
46 |
T cell responses against mutant ras: a basis for novel cancer vaccines
|
Gaudernack, Gustav |
|
1996 |
|
1 |
p. 3-9 7 p. |
artikel |
47 |
Trinucleotide-directed mutagenesis (TRIM) and 2nd generation mini-antibodies
|
Pack, P. |
|
1996 |
|
1 |
p. 70- 1 p. |
artikel |
48 |
Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers
|
Wu, Anna M. |
|
1996 |
|
1 |
p. 21-36 16 p. |
artikel |
49 |
Variation in IgG1 heavy chain allotype does not contribute to differences in biological activity of two human anti-Rhesus (D) monoclonal antibodies
|
Paterson, Trevor |
|
1998 |
|
1 |
p. 37-47 11 p. |
artikel |
50 |
Viral vectors for gene therapy of hematopoietic cells
|
Medin, Jeffrey A. |
|
1997 |
|
1 |
p. 3-19 17 p. |
artikel |